PROGNOSTIC MARKERS IN RESECTABLE NON–SMALL CELL LUNG CANCER
- 1 June 1997
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 11 (3) , 409-434
- https://doi.org/10.1016/s0889-8588(05)70441-x
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Long-term survival of patients with lung cancer from a defined geographical area before and after radiological screeningLung Cancer, 1996
- Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancerCancer, 1994
- Limitation of annual screening chest radiography for the diagnosis of lung cancer. A retrospective studyCancer, 1993
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- DNA content in correlation with postsurgical stage in non-small cell lung cancerThe Annals of Thoracic Surgery, 1992
- The Effect of Surgical Treatment on Survival from Early Lung CancerChest, 1992
- Overexpression of the c‐erbB‐2/neu–encoded p185 protein in primary lung cancerMolecular Carcinogenesis, 1992
- Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Expression of Blood-Group Antigen A — A Favorable Prognostic Factor in Non-Small-Cell Lung CancerNew England Journal of Medicine, 1991
- The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow upCancer, 1989